TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases
TBCRC 022:奈拉替尼联合卡培他滨治疗人表皮生长因子受体2阳性乳腺癌脑转移患者的II期临床试验
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.18.01511
Freedman, Rachel A; Gelman, Rebecca S; Anders, Carey K; Melisko, Michelle E; Parsons, Heather A; Cropp, Anne M; Silvestri, Kelly; Cotter, Christine M; Componeschi, Kathryn P; Marte, Juan M; Connolly, Roisin M; Moy, Beverly; Van Poznak, Catherine H; Blackwell, Kimberly L; Puhalla, Shannon L; Jankowitz, Rachel C; Smith, Karen L; Ibrahim, Nuhad; Moynihan, Timothy J; O'Sullivan, Ciara C; Nangia, Julie; Niravath, Polly; Tung, Nadine; Pohlmann, Paula R; Burns, Robyn; Rimawi, Mothaffar F; Krop, Ian E; Wolff, Antonio C; Winer, Eric P; Lin, Nancy U
肿瘤
肿瘤免疫
信号转导
神经科学
乳腺癌
Human
BCR